Evaluating the Effects of Kombucha as a Hyperglycemic Therapeutic Agent Within Diabetic Human Subjects

Georgetown University

Status: Completed

Conditions: Diabetes Mellitus

Treatments: Dietary Supplement: Ginger Kombucha; Dietary Supplement: Ginger Water

Study type: Interventional

Funder types: Other

Identifiers

NCT04107207

STUDY00001101

Details and patient eligibility

About

This study's primary objective is to determine the ability of Kombucha to impact blood sugar levels in patients with diabetes mellitus type II. The secondary objective is to determine the ability of Kombucha to impact blood pressure, and quality of life measures as measured by uniform questionnaire that includes: gut health, colds, infections, headaches, sleep, anxiety (GAD2), depression (PHQ2), skin health.

Enrollment: 12 patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

1. S/he is above the age of 18
2. S/he has the ability to read, speak and write English
3. S/he has telephone access
4. S/he is diabetic and willing to check blood sugar levels every day
5. Hb A1c >7%
6. Possesses a glucometer

Exclusion criteria

1. Allergy to kombucha ingredients
2. Drinks kombucha regularly (>3time per week)

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: Double Blind

---

12 participants in 2 patient groups, including a placebo group

Kombucha Intervention

Active Comparator group

Description:

Either ginger kombucha or placebo ginger water will be given to subjects for weeks 1-4 and then the reciprocal beverage for weeks 6-10.

Treatment:

Dietary Supplement: Ginger Kombucha

Placebo Intervention

Placebo Comparator group

Description:

Either ginger kombucha or placebo ginger water will be given to subjects for weeks 1-4 and then the reciprocal beverage for weeks 6-10.

Treatment:

Dietary Supplement: Ginger Water